AME Cloud Ventures

Biotech company developing AI-powered multiomics blood tests for early cancer detection. Its platform analyzes cell-free DNA, methylation patterns, and protein biomarkers from routine blood draws to screen for cancers in their earliest stages. Lead product SimpleScreen targets FDA approval for colorectal cancer screening.

Lime is the world's largest shared electric vehicle company, providing electric scooter, e-bike, and e-moped rentals in over 280 cities across nearly 30 countries. The company reported $686 million in revenue for 2024 and has been free cash flow positive for two consecutive years.

Astranis builds small geostationary broadband satellites (MicroGEO) that are roughly 1/20th the size of traditional GEO spacecraft, drastically reducing manufacturing and launch costs. The company operates the satellites it builds and leases dedicated capacity to telecom and internet service providers, connecting underserved regions worldwide.

Spatial data company that turns physical spaces into accurate, immersive 3D digital twins, combining hardware, software, and AI for real estate, construction, and insurance industries.

Rigetti Computing is a full-stack quantum computing company that designs and fabricates superconducting quantum processors, integrates them into quantum computers, and delivers access through its Quantum Cloud Services platform. The company operates the world's first dedicated quantum chip foundry.

Cartography Biosciences is a precision oncology company developing cancer immunotherapies guided by the first comprehensive antigen atlas for immuno-oncology targets. The company's proprietary ATLAS and SUMMIT platforms combine single-cell genomics, proteomics, and computational biology to identify tumor-selective antigens, enabling antibody-based therapies that target tumors more precisely than existing therapeutics.

Clinical-stage precision oncology company that built a proprietary Predictive Precision Medicines Platform (PPMP) to bio-simulate cancer treatments and predict patient response. Originally tested combinations of FDA-approved drugs on patient cancer cell samples for blood cancers. Demonstrated 84% accuracy in predicting treatment responses with Stanford.

AI-powered platform that helps enterprises unlock insights from unstructured image and video data. Coactive's multimodal application platform enables users to search, organize, analyze, and generate metadata from visual content without requiring metadata or manual tagging.